Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma.
Grieb N, Oeser A, Ferle M, Hanke F, Flossdorf S, Sauer S, Goldschmidt H, Müller-Tidow C, Salwender HJ, Fenk R, Engelhardt M, Zeiser R, Vucinic V, Franke GN, Blau IW, Teschner D, Einsele H, Kimmich C, Kull M, Besemer B, Gagelmann N, Kröger N, Neumuth T, Platzbecker U, Merz M; German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST). Grieb N, et al. Among authors: franke gn. Bone Marrow Transplant. 2024 Dec 5. doi: 10.1038/s41409-024-02490-1. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39638882
Thiamine-Responsive Megaloblastic Anemia Syndrome Mimicking Myelodysplastic Neoplasm.
Klötzer C, Schnabel F, Kubasch AS, Jentzsch M, Franke GN, Uhlig J, Faust H, Jauss RT, Oppermann H, Popp D, Metzeler KH, Lemke JR, Vučinić V, Platzbecker U. Klötzer C, et al. Among authors: franke gn. Acta Haematol. 2024 Oct 28:1-5. doi: 10.1159/000542286. Online ahead of print. Acta Haematol. 2024. PMID: 39467528 Free article.
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma.
Fandrei D, Seiffert S, Rade M, Rieprecht S, Gagelmann N, Born P, Wiemers T, Weidner H, Kreuz M, Schassberger T, Koßmann J, Mangold M, Fürst D, Fischer L, Baber R, Heyn S, Wang SY, Bach E, Hoffmann S, Metzeler KH, Herling M, Jentzsch M, Franke GN, Köhl U, Friedrich M, Boldt A, Reiche K, Platzbecker U, Vucinic V, Merz M. Fandrei D, et al. Among authors: franke gn. Blood Cancer Discov. 2025 Jan 8;6(1):38-54. doi: 10.1158/2643-3230.BCD-24-0118. Blood Cancer Discov. 2025. PMID: 39441177
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany.
Arslan A, Labuhn S, Sala E, Ringhoffer M, Schetelig J, Schröder T, Bug G, Franke GN, Stelljes M, Dreger P, Zeiser R, Teschner D, Bethge W, Eder M, Edinger M, Amann EM, Neuchel C, Schmid-Möglich A, Schmeller S, Beyersmann J, Schrezenmeier H, Mytilineos J, Kröger N, Fürst D. Arslan A, et al. Among authors: franke gn. Blood Adv. 2024 Dec 10;8(23):6104-6113. doi: 10.1182/bloodadvances.2024013719. Blood Adv. 2024. PMID: 39368803 Free PMC article.
How risky is a second allogeneic stem cell transplantation?
Penack O, Abouqateb M, Peczynski C, Boreland W, Kröger N, Zeiser R, Ciceri F, Schroeder T, Dreger P, Passweg J, Schetelig J, Stelljes M, Blau IW, Franke GN, Riesner K, Schoemans H, Moiseev I, Peric Z. Penack O, et al. Among authors: franke gn. Leukemia. 2024 Aug;38(8):1799-1807. doi: 10.1038/s41375-024-02318-3. Epub 2024 Jun 25. Leukemia. 2024. PMID: 38918561 Free PMC article.
Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.
Kirchberg J, Fischer L, Born P, Brunner F, Morgner C, Fürst D, Heyn S, Bach E, Brueckner M, Jentzsch M, Wang SY, Böttcher S, Franke GN, Schrezenmeier H, Platzbecker U, Merz M, Vučinić V. Kirchberg J, et al. Among authors: franke gn. Clin Lymphoma Myeloma Leuk. 2024 Sep;24(9):e277-e282. doi: 10.1016/j.clml.2024.05.006. Epub 2024 May 4. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38821728 Free article.
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC).
Niederwieser C, Iacobelli S, Franke GN, Koster L, van Os M, Platzbecker U, Hübel K, Scheid C, Müller LP, Stelljes M, Morozova E, Passweg J, Onida F, Dreger P, Saccardi R, Ladetto M, Salmenniemi U, Bethge W, Poiré X, Kobbe G, McLornan DP, Robin M, Kröger N. Niederwieser C, et al. Among authors: franke gn. Bone Marrow Transplant. 2024 Aug;59(8):1084-1091. doi: 10.1038/s41409-024-02282-7. Epub 2024 Apr 25. Bone Marrow Transplant. 2024. PMID: 38664589 Free PMC article. Clinical Trial.
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
Rade M, Grieb N, Weiss R, Sia J, Fischer L, Born P, Boldt A, Fricke S, Franz P, Scolnick J, Venkatraman L, Xu S, Kloetzer C, Heyn S, Kubasch AS, Baber R, Wang SY, Bach E, Hoffmann S, Ussmann J, Schetschorke B, Hell S, Schwind S, Metzeler KH, Herling M, Jentzsch M, Franke GN, Sack U, Köhl U, Platzbecker U, Reiche K, Vucinic V, Merz M. Rade M, et al. Among authors: franke gn. Nat Cancer. 2024 Sep;5(9):1318-1333. doi: 10.1038/s43018-024-00763-8. Epub 2024 Apr 19. Nat Cancer. 2024. PMID: 38641734
89 results